The results are similar to those previously observed for the second patient cohort analyzed, showing SLC22A18 and SLC22A18AS overexpression in lung adenocarcinoma (p < 0.001 for both genes) and SCC (p = 0.009 and p = 0.048, respectively) with respect to the nontumoral tissues. The gene discussed is SLC67A1; the disease is lung adenocarcinoma.